vs
Side-by-side financial comparison of MIND CTI LTD (MNDO) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $4.9M, roughly 1.3× MIND CTI LTD). MIND CTI LTD runs the higher net margin — 19.4% vs -303.5%, a 322.9% gap on every dollar of revenue.
MIND CTI Ltd. is a global provider of billing and customer care solutions and messaging services for voice, data, video and content services. Headquartered in Yokneam, Israel; the company also has offices in the United States of America, Iaşi in Romania and in Germany.
MNDO vs PRLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.9M | $6.5M |
| Net Profit | $950.0K | $-19.7M |
| Gross Margin | 55.4% | — |
| Operating Margin | 16.5% | -314.1% |
| Net Margin | 19.4% | -303.5% |
| Revenue YoY | — | 116.7% |
| Net Profit YoY | — | 38.9% |
| EPS (diluted) | $0.05 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.9M | — | ||
| Q3 25 | $16.2M | $6.5M | ||
| Q2 25 | $11.0M | — | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $16.0M | $3.0M | ||
| Q2 24 | $10.7M | — | ||
| Q4 23 | $5.6M | — | ||
| Q3 23 | $16.2M | — |
| Q4 25 | $950.0K | — | ||
| Q3 25 | $3.4M | $-19.7M | ||
| Q2 25 | $2.5M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $3.7M | $-32.3M | ||
| Q2 24 | $2.5M | — | ||
| Q4 23 | $1.4M | — | ||
| Q3 23 | $4.0M | — |
| Q4 25 | 55.4% | — | ||
| Q3 25 | 48.3% | — | ||
| Q2 25 | 50.6% | — | ||
| Q4 24 | 55.6% | — | ||
| Q3 24 | 50.6% | — | ||
| Q2 24 | 50.4% | — | ||
| Q4 23 | 49.5% | — | ||
| Q3 23 | 53.9% | — |
| Q4 25 | 16.5% | — | ||
| Q3 25 | 18.8% | -314.1% | ||
| Q2 25 | 21.0% | — | ||
| Q4 24 | 25.4% | — | ||
| Q3 24 | 22.5% | -1145.9% | ||
| Q2 24 | 22.2% | — | ||
| Q4 23 | 20.6% | — | ||
| Q3 23 | 26.7% | — |
| Q4 25 | 19.4% | — | ||
| Q3 25 | 20.9% | -303.5% | ||
| Q2 25 | 22.3% | — | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 23.3% | -1075.7% | ||
| Q2 24 | 23.1% | — | ||
| Q4 23 | 25.6% | — | ||
| Q3 23 | 24.8% | — |
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.16 | $-0.26 | ||
| Q2 25 | $0.12 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $0.18 | $-0.43 | ||
| Q2 24 | $0.12 | — | ||
| Q4 23 | $0.06 | — | ||
| Q3 23 | $0.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $55.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.0M | $58.5M |
| Total Assets | $30.2M | $94.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | — | ||
| Q3 25 | $4.5M | $55.0M | ||
| Q2 25 | $4.5M | — | ||
| Q4 24 | $4.6M | — | ||
| Q3 24 | $3.0M | $153.6M | ||
| Q2 24 | $3.0M | — | ||
| Q4 23 | $16.4M | — | ||
| Q3 23 | $5.3M | — |
| Q4 25 | $23.0M | — | ||
| Q3 25 | $24.3M | $58.5M | ||
| Q2 25 | $24.3M | — | ||
| Q4 24 | $24.3M | — | ||
| Q3 24 | $24.5M | $156.4M | ||
| Q2 24 | $24.5M | — | ||
| Q4 23 | $24.5M | — | ||
| Q3 23 | $23.8M | — |
| Q4 25 | $30.2M | — | ||
| Q3 25 | $30.7M | $94.8M | ||
| Q2 25 | $30.7M | — | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $31.6M | $197.2M | ||
| Q2 24 | $31.6M | — | ||
| Q4 23 | $31.6M | — | ||
| Q3 23 | $31.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-19.1M |
| Free Cash FlowOCF − Capex | $4.0M | — |
| FCF MarginFCF / Revenue | 81.0% | — |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.20× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | — | ||
| Q3 25 | $3.8M | $-19.1M | ||
| Q2 25 | $2.9M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $3.4M | $-27.3M | ||
| Q2 24 | $2.4M | — | ||
| Q4 23 | $4.1M | — | ||
| Q3 23 | $3.1M | — |
| Q4 25 | $4.0M | — | ||
| Q3 25 | $3.8M | — | ||
| Q2 25 | $2.9M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $3.3M | $-27.4M | ||
| Q2 24 | $2.4M | — | ||
| Q4 23 | $4.0M | — | ||
| Q3 23 | $3.0M | — |
| Q4 25 | 81.0% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 25.8% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 20.8% | -912.0% | ||
| Q2 24 | 22.1% | — | ||
| Q4 23 | 72.0% | — | ||
| Q3 23 | 18.6% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | 2.1% | ||
| Q2 24 | 0.4% | — | ||
| Q4 23 | 1.1% | — | ||
| Q3 23 | 0.7% | — |
| Q4 25 | 4.20× | — | ||
| Q3 25 | 1.12× | — | ||
| Q2 25 | 1.16× | — | ||
| Q4 24 | 3.32× | — | ||
| Q3 24 | 0.91× | — | ||
| Q2 24 | 0.97× | — | ||
| Q4 23 | 2.86× | — | ||
| Q3 23 | 0.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
